Literature DB >> 11782905

Intracellular uptake and trafficking of Pluronic micelles in drug-sensitive and MDR cells: effect on the intracellular drug localization.

Natalya Rapoport1, Alexander Marin, Yi Luo, Glenn D Prestwich, M D Muniruzzaman.   

Abstract

The intracellular uptake and localization of a fluorescently labeled Pluronic P-105 in HL-60 leukemia cells and in A2780 drug-sensitive and A2780/ADR MDR ovarian carcinoma cells were characterized by flow cytometry and fluorescence microscopy. Pluronic P-105 molecules were labeled with a pH-sensitive fluorescent label, 5-(and 6-)carboxy-2'7'-dichlorofluorescein. The fluorescence intensity of labeled Pluronic was about twofold higher at pH 7.4 than at pH 5.5. At Pluronic concentrations exceeding the critical micelle concentration (cmc), flow cytometry histograms manifested bimodal distribution of cell fluorescence for all types of cells. Cell population characterized by higher fluorescence intensity presumably resulted from Pluronic transfer from the acidic environment of cytoplasmic vesicles (endosomes or lysosomes) into the neutral environment of the cytoplasm and cell nuclei, which suggested the permeabilization of the membranes of acidic vesicle by Pluronic molecules. For the MDR cells, the bimodal distribution of cell fluorescence was already observed at very low Pluronic concentrations in the incubation medium (i.e., below the cmc). The data suggest that the membranes of acidic vesicles of MDR cells are more susceptible to the action of polymeric surfactants than those of drug-sensitive cells. Permeabilization of acidic vesicles had a dramatic effect on the intracellular trafficking of drugs: when delivered in PBS, the anthracyclin drug ruboxyl (Rb) sequestered in cytoplasmic vesicles and was excluded from cell nuclei; however, when delivered in Pluronic micelles, drug accumulated in cell nuclei. Drug uptake from/with Pluronic micelles was substantially enhanced by ultrasound. These findings suggest that the nuclear accumulation of drugs internalized via fluid-phase endocytosis can be enhanced by the application of Pluronic micelles and can be further augmented by ultrasonic irradiation. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11782905     DOI: 10.1002/jps.10006

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  19 in total

Review 1.  Ultrasonic drug delivery--a general review.

Authors:  William G Pitt; Ghaleb A Husseini; Bryant J Staples
Journal:  Expert Opin Drug Deliv       Date:  2004-11       Impact factor: 6.648

Review 2.  Phase-shift, stimuli-responsive perfluorocarbon nanodroplets for drug delivery to cancer.

Authors:  Natalya Rapoport
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2012-06-22

Review 3.  Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery.

Authors:  Mihaela Aldea; Lucian Craciun; Ciprian Tomuleasa; Ioana Berindan-Neagoe; Gabriel Kacso; Ioan Stefan Florian; Carmen Crivii
Journal:  Tumour Biol       Date:  2014-02-07

4.  Ultrasound-enhanced tumor targeting of polymeric micellar drug carriers.

Authors:  Zhonggao Gao; Heidi D Fain; Natalya Rapoport
Journal:  Mol Pharm       Date:  2004 Jul-Aug       Impact factor: 4.939

5.  Time and dose dependence of pluronic bioactivity in hyperthermia-induced tumor cell death.

Authors:  Tianyi M Krupka; David Dremann; Agata A Exner
Journal:  Exp Biol Med (Maywood)       Date:  2008-11-07

6.  A simple way to enhance Doxil® therapy: drug release from liposomes at the tumor site by amphiphilic block copolymer.

Authors:  Yi Zhao; Daria Y Alakhova; Jong Oh Kim; Tatiana K Bronich; Alexander V Kabanov
Journal:  J Control Release       Date:  2013-03-06       Impact factor: 9.776

Review 7.  The use of ultrasound and micelles in cancer treatment.

Authors:  Ghaleb A Husseini; William G Pitt
Journal:  J Nanosci Nanotechnol       Date:  2008-05

8.  Differential metabolic responses to pluronic in MDR and non-MDR cells: a novel pathway for chemosensitization of drug resistant cancers.

Authors:  Daria Yu Alakhova; Nataliya Y Rapoport; Elena V Batrakova; Alexander A Timoshin; Shu Li; David Nicholls; Valery Yu Alakhov; Alexander V Kabanov
Journal:  J Control Release       Date:  2009-10-06       Impact factor: 9.776

Review 9.  Ultrasonic-activated micellar drug delivery for cancer treatment.

Authors:  Ghaleb A Husseini; William G Pitt
Journal:  J Pharm Sci       Date:  2009-03       Impact factor: 3.534

10.  Cellular distribution studies of the nitric oxide-generating antineoplastic prodrug O(2) -(2,4-dinitrophenyl)1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate formulated in Pluronic P123 micelles.

Authors:  Imit Kaur; Moises Terrazas; Ken M Kosak; Steven E Kern; Kenneth M Boucher; Paul J Shami
Journal:  J Pharm Pharmacol       Date:  2013-07-10       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.